分子細胞遺傳學市場規模、佔有率、成長分析、按產品、按技術、按應用、按最終用戶、按地區 - 產業預測，2024-2031 年

2022年分子細胞遺傳學的全球市場規模估值為23.7億美元，從2023年的25.8億美元成長到2031年的50.2億美元，並預計在預測期內成長（2024-預計複合年成長率為8.7 ） 2031 年的百分比）。

分子細胞遺傳學領域整合了分子生物學和細胞遺傳學，其基礎知識是正常人體細胞有 46 條染色體發揮重要作用。該領域專注於透過螢光雜合反應(FISH) 等技術研究染色體異常，以幫助檢測和治療各種癌症，包括腦腫瘤和骨髓惡性腫瘤。由於癌症、遺傳疾病和人口老化的日益流行，該市場正在經歷顯著成長。此外，醫療保健技術的進步，包括標靶治療的廣泛使用以及試劑和軟體的改進，也有助於提高診斷準確性。生物醫學研究投資的增加進一步推動了市場擴張，並預示著分子細胞遺傳學的強勁未來。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究
• 專利分析

分子細胞遺傳學市場規模：依產品

• 市場概況
• 試劑套件和試劑
  • 檢測套組
  • 探測
  • 螢光和試劑
  • 其他套件和試劑
• 裝置
• 消耗品
• 軟體和服務

分子細胞遺傳學市場規模：依技術分類

• 市場概況
• 比較雜合反應
  • 基於晶片的比較基因組雜合反應
  • 標準比較雜合反應
• 螢光原位雜合技術
• 顯色原位雜合技術
• 核型分析
  • 頻譜
  • 虛擬的
• 其他技術

分子細胞遺傳學市場規模：依應用分類

• 市場概況
• 遺傳疾病
• 癌症
• 個人化醫療
• 其他用途

分子細胞遺傳學市場規模：依最終用戶分類

• 市場概況
• 臨床研究室
• 醫院及病理實驗室
• 學術研究所
• 製藥和生物技術公司
• 其他最終用戶

分子細胞遺傳學市場規模：按地區

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• F. Hoffmann-la roche ltd.
• Agilent technologies, inc.
• Abbott laboratories
• Thermo fisher scientific, inc.
• Illumina inc.
• Revvity
• Pacific biosciences
• Bio-rad laboratories, inc.
• Bio-techne corporation
• Genedx
• Bioview
• Applied spectral imaging, inc.
• Cytotest inc.
• Kromatid, inc.
• Genial genetic solutions ltd.
• Cytognomix, inc.
• Metasystems
• Scigene
• Biomodal
• Biocare medical

結論和建議

Global Molecular Cytogenetics Market size was valued at USD 2.37 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 5.02 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The field of molecular cytogenetics, integrating molecular biology and cytogenetics, plays a crucial role in distinguishing healthy cells from cancerous ones, stemming from the foundational knowledge that normal human cells contain 46 chromosomes. This discipline aids in the detection and treatment of various cancers, including brain tumors and hematological malignancies, focusing on chromosomal abnormalities through techniques like fluorescence in situ hybridization (FISH). The market is witnessing significant growth, driven by the increasing prevalence of cancer, genetic disorders, and an aging population. Additionally, the rising adoption of targeted therapies and advancements in healthcare technology, including improved reagents and software, contribute to enhanced diagnostic accuracy. Increased investment in biomedical research further propels market expansion, projecting a robust future for molecular cytogenetics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Cytogenetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Cytogenetics Market Segmental Analysis

Global Molecular Cytogenetics Market is segmented by product, technique, application, end user and region. Based on product, the market is segmented into kits & reagents, instruments, consumables and software & services. Based on technique, the market is segmented into comparative genomic hybridization, fluorescence in-situ hybridization, chromogenic in-situ hybridization, karyotyping and other techniques. Based on application, the market is segmented into genetic disorders, cancer, personalized medicine and other applications. Based on end user, the market is segmented into clinical & research laboratories, hospitals & path labs, academic research institutes, pharmaceutical & biotechnology companies and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market is poised for significant growth, driven primarily by the rising incidence of cancer cases worldwide. This field, which merges the principles of cytogenetics with molecular biology, is expected to see increased adoption as more healthcare professionals recognize its efficacy in diagnosing and understanding various cancers. The growing prevalence of cancer not only highlights the need for advanced diagnostic tools but also encourages investments and research in molecular cytogenetics, thereby fueling market expansion. As a result, the demand for molecular cytogenetics will likely continue to rise throughout the projected period.

Restraints in the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market faces several significant constraints that could impede its growth. Stringent regulatory requirements pose a challenge, as compliance can be both complex and time-consuming. Additionally, unfavorable reimbursement policies from insurance providers significantly limit access to molecular diagnostic tests, which are essential for early detection of genetic conditions. The high costs associated with these tests, typically ranging around USD 300 each, also create a financial barrier for many patients and healthcare providers. Collectively, these factors contribute to a restrictive environment that hampers the expansion of the molecular cytogenetics market.

Market Trends of the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market is witnessing a robust growth trend, driven primarily by the increasing emphasis on personalized medicine and advanced therapeutic options in oncology. As genomic understanding becomes crucial for effective cancer care-enabling precise diagnostics, tailored treatment plans, and improved survival predictions-the demand for molecular cytogenetic techniques is surging. This market is expected to expand significantly as healthcare providers leverage these technologies for detailed cancer analysis and individualized therapies. As pharmacotherapy and bespoke treatment alternatives gain prominence, the market is poised for lucrative expansion throughout the forecast period, underlining the pivotal role of molecular cytogenetics in modern oncology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis

Global Molecular Cytogenetics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Kits & Reagents
  • Testing Kits
  • Probes
  • Fluorescent Affinity Reagents
  • Other Kits & Reagents
• Instruments
• Consumables
• Software & Services

Global Molecular Cytogenetics Market Size by Technique & CAGR (2024-2031)

• Market Overview
• Comparative Genomic Hybridization
  • Array-Based Comparative Genomic Hybridization
  • Standard Comparative Genomic Hybridization
• Fluorescence In-Situ Hybridization
• Chromogenic In-Situ Hybridization
• Karyotyping
  • Spectral
  • Virtual
• Other Techniques

Global Molecular Cytogenetics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Genetic Disorders
• Cancer
• Personalized Medicine
• Other Applications

Global Molecular Cytogenetics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Clinical & Research Laboratories
• Hospitals & Path Labs
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Other End Users

Global Molecular Cytogenetics Market Size & CAGR (2024-2031)

• North America (Product, Technique, Application, End User)
  • USA
  • Canada
• Europe (Product, Technique, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technique, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technique, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technique, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-la roche ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent technologies, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo fisher scientific, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-rad laboratories, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-techne corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioview
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied spectral imaging, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytotest inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kromatid, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genial genetic solutions ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytognomix, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metasystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scigene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomodal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations